Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/30056
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNappi, Rossella E
dc.contributor.authorLobo Abascal, Paloma
dc.contributor.authorHsieh, Jennifer
dc.contributor.authorMicheletti, Marie-Christine
dc.date.accessioned2019-06-28T16:05:20Z-
dc.date.available2019-06-28T16:05:20Z-
dc.date.issued2017
dc.identifier.citationInt J Womens Health.2017;(9):739-747
dc.identifier.issn1179-1411
dc.identifier.urihttps://hdl.handle.net/20.500.12530/30056-
dc.description.abstractTo evaluate scheduled and unscheduled bleeding and spotting over 1 year of treatment with 91-day extended-regimen combined oral contraception (COC) providing continuous low-dose ethinyl estradiol (EE) in place of the traditional 7-day hormone-free interval (HFI).
dc.language.isoeng
dc.rightsopenAccess-
dc.subject91-day cycle
dc.subjectcombined oral contraception
dc.subjectextended-regimen COC
dc.subjectmenstrual cycle
dc.titleCycle control with an extended-regimen oral contraceptive combining levonorgestrel and ethinyl estradiol that includes continuous low-dose ethinyl estradiol instead of the traditional hormone-free interval.
dc.typeArtículo
dc.identifier.pubmedID29042818
dc.format.volume9
dc.format.page739-747
dc.identifier.journalInternational journal of women's health
dc.identifier.doi10.2147/IJWH.S142078
dc.identifier.pmcPMC5633331
dc.pubmedtypeJournal Article
Appears in Collections:Hospitales > H. U. Infanta Sofía > Artículos

Files in This Item:
File Description SizeFormat 
PMC5633331.pdf676.91 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.